Symbol Name ID |
Slc19a3
solute carrier family 19, member 3 MGI:1931307 |
Darker colors indicate more annotations |
Human Phenotypes | Facial palsy |
Dysphagia |
Opisthotonus |
Frequent falls |
Abnormal basal ganglia morphology |
Abnormal pyramidal tract morphology |
Gait ataxia |
Chorea |
Action tremor |
Truncal titubation |
Abnormal pyramidal sign |
Babinski sign |
Paraparesis |
Tetraparesis |
Dysarthria |
Loss of speech |
Mutism |
Irritability |
Lethargy |
Confusion |
Coma |
Dystonia |
Craniofacial dystonia |
Inability to walk |
Encephalopathy |
Developmental regression |
Global developmental delay |
Seizure |
Disease(s) Associated with SLC19A3 | ||||||||||||||||||||||||||||
biotin-responsive basal ganglia disease |
Mouse Phenotypes | astrocytosis |
decreased neuron number |
neurodegeneration |
|
Availability | Mouse Genotype | |||
Slc19a3tm1.1Nwak/Slc19a3tm1.1Nwak | ||||
Slc19a3tm1Said/Slc19a3tm1Said |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/30/2024 MGI 6.23 |
|
|